RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE

NCT01082146 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Metabolism

Interventions

DRUG: Lurasidone

Sponsor

Sumitomo Pharma America, Inc.